25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

TUB (Tubize-Fin) Stock Analysis
Buy, Hold or Sell?

Let's analyze Tubize-Fin together

I guess you are interested in Tubize-Fin. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Tubize-Fin’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Tubize-Fin’s Price Targets

I'm going to help you getting a better view of Tubize-Fin. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Tubize-Fin

I send you an email if I find something interesting about Tubize-Fin.

1. Quick Overview

1.1. Quick analysis of Tubize-Fin (30 sec.)










1.2. What can you expect buying and holding a share of Tubize-Fin? (30 sec.)

How much money do you get?

How much money do you get?
€4.52
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€41.35
Expected worth in 1 year
€45.28
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
€7.82
Return On Investment
3.4%

For what price can you sell your share?

Current Price per Share
€228.00
Expected price per share
€153.47 - €241.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Tubize-Fin (5 min.)




Live pricePrice per Share (EOD)
€228.00
Intrinsic Value Per Share
€5.27 - €10.72
Total Value Per Share
€46.61 - €52.07

2.2. Growth of Tubize-Fin (5 min.)




Is Tubize-Fin growing?

Current yearPrevious yearGrowGrow %
How rich?$2.1b$2b$51m2.4%

How much money is Tubize-Fin making?

Current yearPrevious yearGrowGrow %
Making money$105m$102.7m$2.2m2.2%
Net Profit Margin679,673.6%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Tubize-Fin (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#36 / 848

Most Revenue
#659 / 848

Most Profit
#26 / 848
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Tubize-Fin?

Welcome investor! Tubize-Fin's management wants to use your money to grow the business. In return you get a share of Tubize-Fin.

First you should know what it really means to hold a share of Tubize-Fin. And how you can make/lose money.

Speculation

The Price per Share of Tubize-Fin is €228.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tubize-Fin.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tubize-Fin, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €41.35. Based on the TTM, the Book Value Change Per Share is €0.98 per quarter. Based on the YOY, the Book Value Change Per Share is €1.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.97 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tubize-Fin.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps2.361.0%2.361.0%2.311.0%2.301.0%4.732.1%5.632.5%
Usd Book Value Change Per Share1.150.5%1.150.5%1.180.5%-12.28-5.4%-4.31-1.9%0.590.3%
Usd Dividend Per Share1.130.5%1.130.5%1.000.4%1.000.4%0.900.4%0.760.3%
Usd Total Gains Per Share2.281.0%2.281.0%2.181.0%-11.27-4.9%-3.41-1.5%1.350.6%
Usd Price Per Share165.73-165.73-83.57-110.61-106.67-90.10-
Price to Earnings Ratio70.25-70.25-36.21-47.82-33.63-22.64-
Price-to-Total Gains Ratio72.77-72.77-38.33-36.31-28.16-26.14-
Price to Book Ratio3.44-3.44-1.78-2.34-1.91-1.60-
Price-to-Total Gains Ratio72.77-72.77-38.33-36.31-28.16-26.14-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share265.734
Number of shares3
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share1.130.90
Usd Book Value Change Per Share1.15-4.31
Usd Total Gains Per Share2.28-3.41
Gains per Quarter (3 shares)6.83-10.23
Gains per Year (3 shares)27.33-40.92
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
114141711-52-51
227284422-104-92
341417133-155-133
454559843-207-174
5686912554-259-215
6818315265-311-256
7959617976-362-297
810911020687-414-338
912212423398-466-379
10136138260109-518-420

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%21.01.00.095.5%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%18.04.00.081.8%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%21.00.01.095.5%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%18.04.00.081.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Tubize-Fin compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.9840.9840%1.010-3%-10.532+1170%-3.702+476%0.509+93%
Book Value Per Share--41.34641.3460%40.361+2%40.353+2%51.349-19%50.430-18%
Current Ratio--0.0170.0170%0.005+223%0.012+44%0.165-90%0.091-82%
Debt To Asset Ratio--0.0460.0460%0.064-28%0.053-12%0.035+31%0.061-24%
Debt To Equity Ratio--0.0490.0490%0.069-30%0.056-13%0.037+31%0.067-27%
Dividend Per Share--0.9700.9700%0.860+13%0.860+13%0.776+25%0.648+50%
Enterprise Value--6241844436.6006241844436.6000%3068477965.600+103%4125232604.867+51%4006722801.760+56%3308159393.859+89%
Eps--2.0242.0240%1.980+2%1.973+3%4.062-50%4.834-58%
Ev To Ebitda Ratio---2792.129-2792.1290%16624.919-117%4622.643-160%2776.031-201%-2577.456-8%
Ev To Sales Ratio--470833.857470833.8570%--423453.698+11%423453.698+11%641108.314-27%
Free Cash Flow Per Share---0.046-0.0460%-0.046-1%1.274-104%0.750-106%1.001-105%
Free Cash Flow To Equity Per Share---1.941-1.9410%-0.265-86%0.517-476%-0.275-86%-0.060-97%
Gross Profit Margin--1.0001.0000%0.999+0%1.000+0%1.000+0%1.000+0%
Intrinsic Value_10Y_max--10.719----------
Intrinsic Value_10Y_min--5.267----------
Intrinsic Value_1Y_max--1.234----------
Intrinsic Value_1Y_min--0.701----------
Intrinsic Value_3Y_max--3.585----------
Intrinsic Value_3Y_min--1.968----------
Intrinsic Value_5Y_max--5.790----------
Intrinsic Value_5Y_min--3.076----------
Market Cap10148872344.000+38%6329691435.6006329691435.6000%3191553276.600+98%4224245550.200+50%4073792968.960+55%3441653477.459+84%
Net Profit Margin--6796.7366796.7360%-+100%5748.582+18%3449.149+97%32494.174-79%
Operating Margin---168.664-168.6640%--100%3436.596-105%2061.958-108%10465.473-102%
Operating Ratio--169.664169.6640%-+100%131.097+29%78.658+116%1091.991-84%
Pb Ratio5.514+38%3.4393.4390%1.776+94%2.338+47%1.914+80%1.604+114%
Pe Ratio112.635+38%70.24870.2480%36.205+94%47.819+47%33.629+109%22.638+210%
Price Per Share228.000+38%142.200142.2000%71.700+98%94.900+50%91.520+55%77.303+84%
Price To Free Cash Flow Ratio-4905.207-60%-3059.300-3059.3000%-1559.899-49%-1533.703-50%-1962.619-36%-1211.592-60%
Price To Total Gains Ratio116.671+38%72.76672.7660%38.335+90%36.315+100%28.157+158%26.143+178%
Quick Ratio--0.0160.0160%0.005+211%0.011+44%14.575-100%7.296-100%
Return On Assets--0.0470.0470%0.046+2%0.046+1%0.069-33%0.086-46%
Return On Equity--0.0490.0490%0.0490%0.049+0%0.071-31%0.092-47%
Total Gains Per Share--1.9541.9540%1.870+4%-9.672+595%-2.926+250%1.157+69%
Usd Book Value--2144992640.5532144992640.5530%2093930655.485+2%2093478939.153+2%2663947727.192-19%2616868615.996-18%
Usd Book Value Change Per Share--1.1471.1470%1.178-3%-12.275+1170%-4.315+476%0.594+93%
Usd Book Value Per Share--48.18848.1880%47.041+2%47.031+2%59.847-19%58.776-18%
Usd Dividend Per Share--1.1311.1310%1.002+13%1.002+13%0.904+25%0.755+50%
Usd Enterprise Value--7274869690.8577274869690.8570%3576311068.907+103%4807958600.972+51%4669835425.451+56%3855659773.543+89%
Usd Eps--2.3592.3590%2.308+2%2.299+3%4.734-50%5.635-58%
Usd Free Cash Flow---2411419.500-2411419.5000%-2384613.000-1%66087856.212-104%38893507.027-106%51931569.514-105%
Usd Free Cash Flow Per Share---0.054-0.0540%-0.054-1%1.485-104%0.874-106%1.166-105%
Usd Free Cash Flow To Equity Per Share---2.263-2.2630%-0.309-86%0.602-476%-0.320-86%-0.069-97%
Usd Market Cap11828510716.932+38%7377255368.1927377255368.1920%3719755343.877+98%4923358188.758+50%4748005705.323+55%4011247127.978+84%
Usd Price Per Share265.734+38%165.734165.7340%83.566+98%110.606+50%106.667+55%90.097+84%
Usd Profit--105016595.450105016595.4500%102740301.689+2%102340800.534+3%210730438.220-50%250878593.410-58%
Usd Revenue--15451.03415451.0340%-+100%8317.008+86%4990.205+210%65362569.602-100%
Usd Total Gains Per Share--2.2782.2780%2.180+4%-11.273+595%-3.410+250%1.349+69%
 EOD+5 -3MRQTTM+0 -0YOY+25 -143Y+29 -115Y+17 -2310Y+17 -23

3.3 Fundamental Score

Let's check the fundamental score of Tubize-Fin based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15112.635
Price to Book Ratio (EOD)Between0-15.514
Net Profit Margin (MRQ)Greater than06,796.736
Operating Margin (MRQ)Greater than0-168.664
Quick Ratio (MRQ)Greater than10.016
Current Ratio (MRQ)Greater than10.017
Debt to Asset Ratio (MRQ)Less than10.046
Debt to Equity Ratio (MRQ)Less than10.049
Return on Equity (MRQ)Greater than0.150.049
Return on Assets (MRQ)Greater than0.050.047
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Tubize-Fin based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose225.000
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Tubize-Fin

Financière de Tubize SA operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. It engages in discovering and developing treatments for patients suffering from serious illnesses that affects immune system or central nervous system. The company was incorporated in 1928 and is based in Brussels, Belgium.

Fundamental data was last updated by Penke on 2025-10-15 14:47:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Tubize-Fin earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Tubize-Fin to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 679,673.6%Β means thatΒ €6,796.74 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tubize-Fin:

  • The MRQ is 679,673.6%. The company is making a huge profit. +2
  • The TTM is 679,673.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ679,673.6%TTM679,673.6%0.0%
TTM679,673.6%YOY-+679,673.6%
TTM679,673.6%5Y344,914.9%+334,758.7%
5Y344,914.9%10Y3,249,417.4%-2,904,502.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ679,673.6%-77.6%+679,751.2%
TTM679,673.6%-167.4%+679,841.0%
YOY--186.6%+186.6%
3Y574,858.2%-264.1%+575,122.3%
5Y344,914.9%-344.5%+345,259.4%
10Y3,249,417.4%-475.7%+3,249,893.1%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Tubize-Fin is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Tubize-Fin to theΒ Biotechnology industry mean.
  • 4.7% Return on Assets means thatΒ Tubize-Fin generatedΒ €0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tubize-Fin:

  • The MRQ is 4.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.7%TTM4.7%0.0%
TTM4.7%YOY4.6%+0.1%
TTM4.7%5Y6.9%-2.3%
5Y6.9%10Y8.6%-1.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.7%-11.9%+16.6%
TTM4.7%-11.8%+16.5%
YOY4.6%-11.0%+15.6%
3Y4.6%-12.0%+16.6%
5Y6.9%-11.7%+18.6%
10Y8.6%-13.8%+22.4%
4.3.1.3. Return on Equity

Shows how efficient Tubize-Fin is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Tubize-Fin to theΒ Biotechnology industry mean.
  • 4.9% Return on Equity means Tubize-Fin generated €0.05Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tubize-Fin:

  • The MRQ is 4.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.9%TTM4.9%0.0%
TTM4.9%YOY4.9%0.0%
TTM4.9%5Y7.1%-2.2%
5Y7.1%10Y9.2%-2.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9%-14.2%+19.1%
TTM4.9%-14.8%+19.7%
YOY4.9%-15.0%+19.9%
3Y4.9%-16.6%+21.5%
5Y7.1%-16.8%+23.9%
10Y9.2%-19.5%+28.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Tubize-Fin.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Tubize-Fin is operatingΒ .

  • Measures how much profit Tubize-Fin makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Tubize-Fin to theΒ Biotechnology industry mean.
  • An Operating Margin of -16,866.4%Β means the company generated €-168.66 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tubize-Fin:

  • The MRQ is -16,866.4%. The company is operating very inefficient. -2
  • The TTM is -16,866.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-16,866.4%TTM-16,866.4%0.0%
TTM-16,866.4%YOY--16,866.4%
TTM-16,866.4%5Y206,195.8%-223,062.1%
5Y206,195.8%10Y1,046,547.3%-840,351.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16,866.4%-155.0%-16,711.4%
TTM-16,866.4%-266.6%-16,599.8%
YOY--247.8%+247.8%
3Y343,659.6%-250.4%+343,910.0%
5Y206,195.8%-345.8%+206,541.6%
10Y1,046,547.3%-503.1%+1,047,050.4%
4.3.2.2. Operating Ratio

Measures how efficient Tubize-Fin is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 169.66 means that the operating costs are €169.66 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Tubize-Fin:

  • The MRQ is 169.664. The company is inefficient in keeping operating costs low. -1
  • The TTM is 169.664. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ169.664TTM169.6640.000
TTM169.664YOY-+169.664
TTM169.6645Y78.658+91.006
5Y78.65810Y1,091.991-1,013.333
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ169.6641.882+167.782
TTM169.6642.793+166.871
YOY-2.810-2.810
3Y131.0973.587+127.510
5Y78.6584.650+74.008
10Y1,091.9916.271+1,085.720
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Tubize-Fin.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Tubize-Fin is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 0.02Β means the company has €0.02 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Tubize-Fin:

  • The MRQ is 0.017. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.017. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.017TTM0.0170.000
TTM0.017YOY0.005+0.012
TTM0.0175Y0.165-0.148
5Y0.16510Y0.091+0.074
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0173.414-3.397
TTM0.0173.623-3.606
YOY0.0054.035-4.030
3Y0.0124.425-4.413
5Y0.1655.714-5.549
10Y0.0916.116-6.025
4.4.3.2. Quick Ratio

Measures if Tubize-Fin is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Tubize-Fin to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.02Β means the company can pay off €0.02 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tubize-Fin:

  • The MRQ is 0.016. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.016. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.016TTM0.0160.000
TTM0.016YOY0.005+0.011
TTM0.0165Y14.575-14.559
5Y14.57510Y7.296+7.279
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0162.912-2.896
TTM0.0163.149-3.133
YOY0.0053.831-3.826
3Y0.0114.379-4.368
5Y14.5755.697+8.878
10Y7.2966.523+0.773
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Tubize-Fin.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Tubize-FinΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Tubize-Fin to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.05Β means that Tubize-Fin assets areΒ financed with 4.6% credit (debt) and the remaining percentage (100% - 4.6%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Tubize-Fin:

  • The MRQ is 0.046. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.046. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.046TTM0.0460.000
TTM0.046YOY0.064-0.018
TTM0.0465Y0.035+0.011
5Y0.03510Y0.061-0.026
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0460.342-0.296
TTM0.0460.359-0.313
YOY0.0640.329-0.265
3Y0.0530.344-0.291
5Y0.0350.348-0.313
10Y0.0610.378-0.317
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Tubize-Fin is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Tubize-Fin to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 4.9% means that company has €0.05 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tubize-Fin:

  • The MRQ is 0.049. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.049. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.049TTM0.0490.000
TTM0.049YOY0.069-0.020
TTM0.0495Y0.037+0.011
5Y0.03710Y0.067-0.030
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0490.400-0.351
TTM0.0490.439-0.390
YOY0.0690.431-0.362
3Y0.0560.470-0.414
5Y0.0370.467-0.430
10Y0.0670.517-0.450
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Tubize-Fin generates.

  • Above 15 is considered overpriced butΒ always compareΒ Tubize-Fin to theΒ Biotechnology industry mean.
  • A PE ratio of 70.25 means the investor is paying €70.25Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tubize-Fin:

  • The EOD is 112.635. Based on the earnings, the company is expensive. -2
  • The MRQ is 70.248. Based on the earnings, the company is expensive. -2
  • The TTM is 70.248. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD112.635MRQ70.248+42.386
MRQ70.248TTM70.2480.000
TTM70.248YOY36.205+34.043
TTM70.2485Y33.629+36.620
5Y33.62910Y22.638+10.991
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD112.635-2.920+115.555
MRQ70.248-2.294+72.542
TTM70.248-2.690+72.938
YOY36.205-3.622+39.827
3Y47.819-3.859+51.678
5Y33.629-5.932+39.561
10Y22.638-6.948+29.586
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tubize-Fin:

  • The EOD is -4,905.207. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3,059.300. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3,059.300. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4,905.207MRQ-3,059.300-1,845.907
MRQ-3,059.300TTM-3,059.3000.000
TTM-3,059.300YOY-1,559.899-1,499.401
TTM-3,059.3005Y-1,962.619-1,096.681
5Y-1,962.61910Y-1,211.592-751.026
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4,905.207-3.683-4,901.524
MRQ-3,059.300-2.922-3,056.378
TTM-3,059.300-3.871-3,055.429
YOY-1,559.899-4.346-1,555.553
3Y-1,533.703-5.307-1,528.396
5Y-1,962.619-8.378-1,954.241
10Y-1,211.592-9.842-1,201.750
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Tubize-Fin is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 3.44 means the investor is paying €3.44Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Tubize-Fin:

  • The EOD is 5.514. Based on the equity, the company is overpriced. -1
  • The MRQ is 3.439. Based on the equity, the company is fair priced.
  • The TTM is 3.439. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.514MRQ3.439+2.075
MRQ3.439TTM3.4390.000
TTM3.439YOY1.776+1.663
TTM3.4395Y1.914+1.525
5Y1.91410Y1.604+0.310
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.5142.524+2.990
MRQ3.4392.071+1.368
TTM3.4392.250+1.189
YOY1.7762.465-0.689
3Y2.3382.698-0.360
5Y1.9143.840-1.926
10Y1.6044.569-2.965
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-12-312021-12-312022-12-312023-12-312024-12-31
EBITDA  524,125237,351761,476-674,24387,233-87,048185-2,420-2,236



6.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets1,929,682
Total Liabilities89,276
Total Stockholder Equity1,840,406
 As reported
Total Liabilities 89,276
Total Stockholder Equity+ 1,840,406
Total Assets = 1,929,682

Assets

Total Assets1,929,682
Total Current Assets1,492
Long-term Assets1,928,189
Total Current Assets
Cash And Cash Equivalents 1,429
Net Receivables 9
Other Current Assets 55
Total Current Assets  (as reported)1,492
Total Current Assets  (calculated)1,492
+/-0
Long-term Assets
Property Plant Equipment 2
Long-term Assets Other 1,928,187
Long-term Assets  (as reported)1,928,189
Long-term Assets  (calculated)1,928,189
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities89,276
Long-term Liabilities46,299
Total Stockholder Equity1,840,406
Total Current Liabilities
Short-term Debt 41,300
Short Long Term Debt 41,300
Accounts payable 510
Other Current Liabilities 47,466
Total Current Liabilities  (as reported)89,276
Total Current Liabilities  (calculated)130,576
+/- 41,300
Long-term Liabilities
Long-term Liabilities  (as reported)46,299
Long-term Liabilities  (calculated)0
+/- 46,299
Total Stockholder Equity
Common Stock235,000
Retained Earnings 135,051
Accumulated Other Comprehensive Income 1,469,130
Other Stockholders Equity 1,225
Total Stockholder Equity (as reported)1,840,406
Total Stockholder Equity (calculated)1,840,406
+/-0
Other
Capital Stock235,000
Cash and Short Term Investments 1,429
Common Stock Shares Outstanding 44,513
Liabilities and Stockholders Equity 1,929,682
Net Debt 39,871
Net Invested Capital 1,881,706
Net Working Capital -87,784
Property Plant and Equipment Gross 2
Short Long Term Debt Total 41,300



6.3. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
525,305
647,273
748,105
791,029
715,254
1,018,916
1,595,335
1,674,974
1,585,273
1,723,704
1,784,905
1,868,665
1,785,998
1,804,734
1,835,424
2,259,155
2,222,819
2,311,329
2,483,601
2,751,764
2,827,158
3,267,764
1,838,806
1,920,244
1,929,682
1,929,6821,920,2441,838,8063,267,7642,827,1582,751,7642,483,6012,311,3292,222,8192,259,1551,835,4241,804,7341,785,9981,868,6651,784,9051,723,7041,585,2731,674,9741,595,3351,018,916715,254791,029748,105647,273525,305
   > Total Current Assets 
0
0
0
11,583
10,103
12,527
9,671
8,884
8,916
2,812
764
789
200
504
388
612
689
1,485
1,662
526
1,033
15,930
1,118
635
1,492
1,4926351,11815,9301,0335261,6621,4856896123885042007897642,8128,9168,8849,67112,52710,10311,583000
       Cash And Cash Equivalents 
130
308
191
588
4,877
7,190
9,658
8,869
8,793
2,798
757
779
193
476
354
565
662
1,452
1,529
462
983
15,900
1,069
575
1,429
1,4295751,06915,9009834621,5291,4526625653544761937797572,7988,7938,8699,6587,1904,877588191308130
       Short-term Investments 
0
0
530
500
4,300
0
0
0
0
0
0
0
0
54,654
0
0
0
0
0
0
0
1,508,613
0
0
0
0001,508,613000000054,654000000004,30050053000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
0
0
102
30
0
1
1
60
9
960110301020013000000000000000
       Other Current Assets 
0
0
0
10,995
5,226
5,337
13
15
123
14
7
10
7
27
33
47
27
33
133
64
50
29
49
60
55
556049295064133332747332771071412315135,3375,22610,995000
   > Long-term Assets 
0
0
0
779,446
705,151
1,006,389
1,585,664
1,666,090
1,576,357
1,720,892
1,784,141
1,867,876
1,785,798
1,804,230
1,835,036
2,258,543
2,222,130
2,309,844
2,481,939
2,751,238
2,826,125
3,251,834
1,837,687
1,919,609
1,928,189
1,928,1891,919,6091,837,6873,251,8342,826,1252,751,2382,481,9392,309,8442,222,1302,258,5431,835,0361,804,2301,785,7981,867,8761,784,1411,720,8921,576,3571,666,0901,585,6641,006,389705,151779,446000
       Property Plant Equipment 
1
1
0
0
0
0
0
8
0
4
2
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2000000000000024080000011
       Goodwill 
34,887
63,125
69,240
33,978
10,246
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000010,24633,97869,24063,12534,887
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,749,576
1,835,036
2,258,543
2,222,130
2,309,844
2,481,939
2,751,238
0
0
0
0
0
000002,751,2382,481,9392,309,8442,222,1302,258,5431,835,0361,749,5760000000000000
       Intangible Assets 
34,887
63,125
69,240
33,978
10,246
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000010,24633,97869,24063,12534,887
       Long-term Assets Other 
0
0
0
779,446
705,151
1,006,389
1,585,664
1,666,090
1,576,357
1,720,888
1,784,139
1,867,876
1,785,798
54,654
1,835,036
-576
-134
2,309,844
2,481,939
-2,751,238
2,826,125
1,508,613
1,837,687
1,919,609
1,928,187
1,928,1871,919,6091,837,6871,508,6132,826,125-2,751,2382,481,9392,309,844-134-5761,835,03654,6541,785,7981,867,8761,784,1391,720,8881,576,3571,666,0901,585,6641,006,389705,151779,446000
> Total Liabilities 
81,874
128,844
171,451
156,121
122,696
117,522
240,309
413,794
389,921
366,636
340,973
320,313
293,532
253,230
213,548
311,841
265,264
195,653
144,038
87,464
34,257
20,938
87,185
123,650
89,276
89,276123,65087,18520,93834,25787,464144,038195,653265,264311,841213,548253,230293,532320,313340,973366,636389,921413,794240,309117,522122,696156,121171,451128,84481,874
   > Total Current Liabilities 
0
0
0
29,052
24,843
32,207
34,336
40,854
46,675
34,748
34,214
38,618
37,764
57,806
50,299
52,101
103,035
54,912
53,720
53,369
34,257
20,938
86,732
122,715
89,276
89,276122,71586,73220,93834,25753,36953,72054,912103,03552,10150,29957,80637,76438,61834,21434,74846,67540,85434,33632,20724,84329,052000
       Short-term Debt 
0
0
0
0
22,533
29,780
29,533
0
29,533
30,000
30,000
35,000
35,000
57,056
49,506
50,953
102,559
54,396
53,184
52,500
33,618
20,041
47,800
79,200
41,300
41,30079,20047,80020,04133,61852,50053,18454,396102,55950,95349,50657,05635,00035,00030,00030,00029,533029,53329,78022,5330000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
231,702
49,506
50,953
99,997
52,144
52,613
52,561
33,516
20,041
47,800
79,200
41,300
41,30079,20047,80020,04133,51652,56152,61352,14499,99750,95349,506231,7020000000000000
       Accounts payable 
0
0
0
0
81
411
829
0
622
681
762
777
729
11
39
70
34
80
104
110
149
467
196
263
510
51026319646714911010480347039117297777626816220829411810000
       Other Current Liabilities 
0
0
0
29,052
2,229
2,016
3,974
40,854
16,520
4,067
4,214
2,841
2,035
739
754
1,078
442
436
432
418
490
430
38,708
43,192
47,466
47,46643,19238,7084304904184324364421,0787547392,0352,8414,2144,06716,52040,8543,9742,0162,22929,052000
   > Long-term Liabilities 
0
0
0
127,069
97,853
85,315
205,973
372,940
343,246
331,888
306,759
281,695
255,768
195,424
163,249
259,740
162,229
140,741
90,318
34,095
757
117
453
935
46,299
46,29993545311775734,09590,318140,741162,229259,740163,249195,424255,768281,695306,759331,888343,246372,940205,97385,31597,853127,069000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
236,935
141,000
140,000
90,000
34,000
0
0
0
0
0
0000034,00090,000140,000141,000236,935000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,464
0
0
0
0
0
0
0
0
0000000019,4640000000000000000
> Total Stockholder Equity
443,431
518,429
576,654
250,070
592,558
901,394
1,355,026
1,261,180
1,195,352
1,357,068
1,443,932
1,548,352
1,492,466
1,551,504
1,621,876
1,947,314
1,957,555
2,115,676
2,339,563
2,664,300
2,792,901
3,246,826
1,751,620
1,796,594
1,840,406
1,840,4061,796,5941,751,6203,246,8262,792,9012,664,3002,339,5632,115,6761,957,5551,947,3141,621,8761,551,5041,492,4661,548,3521,443,9321,357,0681,195,3521,261,1801,355,026901,394592,558250,070576,654518,429443,431
   Common Stock
66,000
66,000
66,000
169,000
66,000
235,000
235,000
471,225
235,000
235,000
235,000
235,000
236,225
235,000
235,000
235,000
235,000
235,000
236,225
235,000
236,225
236,225
236,225
235,000
235,000
235,000235,000236,225236,225236,225235,000236,225235,000235,000235,000235,000235,000236,225235,000235,000235,000235,000471,225235,000235,00066,000169,00066,00066,00066,000
   Retained Earnings Total Equity0000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
-22,481
9,976
44,602
-9,450
-98,120
-132,744
-63,448
-153,456
1,347,109
1,425,355
1,446,399
1,469,130
1,469,1301,446,3991,425,3551,347,109-153,456-63,448-132,744-98,120-9,45044,6029,976-22,4810000000000000
   Capital Surplus 0000000000000000000000000
   Treasury Stock00000-137,558-126,808-130,844-102,256-104,268-59,424-61,237-86,482-95,031-45,289-45,324-48,811-49,482-48,529000000
   Other Stockholders Equity 
0
0
0
81,070
-34,334
-36,659
-28,188
-29,141
-77,613
1,225
1,225
45,486
1,225
-60,012
-58,199
-103,043
-101,031
-129,619
-391,071
-199,781
-448,744
-1,686,658
0
25,181
1,225
1,22525,1810-1,686,658-448,744-199,781-391,071-129,619-101,031-103,043-58,199-60,0121,22545,4861,2251,225-77,613-29,141-28,188-36,659-34,33481,070000



6.4. Balance Sheets

Currency in EUR. All numbers in thousands.




6.5. Cash Flows

Currency in EUR. All numbers in thousands.




6.6. Income Statements

Currency in EUR. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue13
Cost of Revenue-2,237
Gross Profit-2,223-2,223
 
Operating Income (+$)
Gross Profit-2,223
Operating Expense-13
Operating Income-2,236-2,236
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense130
 
Net Interest Income (+$)
Interest Income25
Interest Expense-2,497
Other Finance Cost-1,057
Net Interest Income-3,529
 
Pretax Income (+$)
Operating Income-2,236
Net Interest Income-3,529
Other Non-Operating Income Expenses0
Income Before Tax (EBT)90,104-94,576
EBIT - interestExpense = -4,733
90,104
92,601
Interest Expense2,497
Earnings Before Interest and Taxes (EBIT)-2,23692,601
Earnings Before Interest and Taxes (EBITDA)-2,236
 
After tax Income (+$)
Income Before Tax90,104
Tax Provision-0
Net Income From Continuing Ops90,10490,104
Net Income90,104
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,249
Total Other Income/Expenses Net92,3403,529
 

Technical Analysis of Tubize-Fin
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tubize-Fin. The general trend of Tubize-Fin is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tubize-Fin's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Tubize-Fin Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tubize-Fin.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 241.00.

The bearish price targets are: 172.80 > 158.40 > 153.47.

Know someone who trades $TUB? Share this with them.πŸ‘‡

Tubize-Fin Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tubize-Fin. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tubize-Fin Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tubize-Fin.

Tubize-Fin Daily Moving Average Convergence/Divergence (MACD) ChartTubize-Fin Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tubize-Fin. The current adx is .

Tubize-Fin Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tubize-Fin.

Tubize-Fin Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tubize-Fin.

Tubize-Fin Daily Relative Strength Index (RSI) ChartTubize-Fin Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tubize-Fin.

Tubize-Fin Daily Stochastic Oscillator ChartTubize-Fin Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tubize-Fin.

Tubize-Fin Daily Commodity Channel Index (CCI) ChartTubize-Fin Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tubize-Fin.

Tubize-Fin Daily Chande Momentum Oscillator (CMO) ChartTubize-Fin Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tubize-Fin.

Tubize-Fin Daily Williams %R ChartTubize-Fin Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Tubize-Fin.

Tubize-Fin Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tubize-Fin.

Tubize-Fin Daily Average True Range (ATR) ChartTubize-Fin Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tubize-Fin.

Tubize-Fin Daily On-Balance Volume (OBV) ChartTubize-Fin Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tubize-Fin.

Tubize-Fin Daily Money Flow Index (MFI) ChartTubize-Fin Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tubize-Fin.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-31BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-05BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-08-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-08-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-09-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-09-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-09-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-09-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-01STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-10-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-10MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-10-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Tubize-Fin Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tubize-Fin based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose225.000
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Tubize-Fin with someone you think should read this too:
  • Are you bullish or bearish on Tubize-Fin? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tubize-Fin? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tubize-Fin

I send you an email if I find something interesting about Tubize-Fin.


Comments

How you think about this?

Leave a comment

Stay informed about Tubize-Fin.

Receive notifications about Tubize-Fin in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.